NeuroBo Pharmaceuticals, Inc. (NRBO)
NASDAQ: NRBO · IEX Real-Time Price · USD
4.510
0.00 (0.00%)
At close: Jul 19, 2024, 4:00 PM
4.900
+0.390 (8.65%)
Pre-market: Jul 22, 2024, 7:18 AM EDT
NeuroBo Pharmaceuticals Market Cap
NeuroBo Pharmaceuticals has a market cap or net worth of $25.57 million as of July 22, 2024. Its market cap has increased by 113.07% in one year.
Market Cap
25.57M
Enterprise Value
9.77M
1-Year Change
113.07%
Ranking
Category
Stock Price
$4.51
Market Cap Chart
Since August 5, 2016, NeuroBo Pharmaceuticals's market cap has decreased from $84.50M to $25.57M, a decrease of -69.74%. That is a compound annual growth rate of -13.95%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 19, 2024 | 22.10M | 23.46% |
Dec 29, 2023 | 17.90M | 280.85% |
Dec 30, 2022 | 4.70M | -85.49% |
Dec 31, 2021 | 32.40M | -62.41% |
Dec 31, 2020 | 86.20M | 1,557.69% |
Dec 31, 2019 | 5.20M | -55.17% |
Dec 31, 2018 | 11.60M | -86.27% |
Dec 29, 2017 | 84.50M | 16.23% |
Dec 30, 2016 | 72.70M | -13.96% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Renalytix | 26.57M |
Autonomix Medical | 26.50M |
SAB Biotherapeutics | 26.21M |
Beyond Air | 26.06M |
ATI Physical Therapy | 25.89M |
NanoViricides | 25.05M |
NRx Pharmaceuticals | 24.93M |
Accelerate Diagnostics | 24.70M |